$1.15B project allows FDA to centralize

In the great chess game of managing the government's properties, the FDA is consolidating its previously scattered labs and offices to a former Navy site in White Oak, MD. The $1.15 billion project--which includes 14 new buildings totaling 3.1 million square feet of labs and offices--is also expected to become the anchor of a new biotech hub just outside the Capital Beltway. Report

Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.